Millennium Management
CMPX icon

Millennium Management’s Compass Therapeutics CMPX Stock Holding History

Millennium Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
4,713,247
+3,867,027
+457% +$11.4M ﹤0.01% 2248
2026
Q1 		$4.48M Sell
846,220
-2,263,066
-73% -$13.1M ﹤0.01% 3080
2025
Q4 		$16.7M Sell
3,109,286
-128,286
-4% -$592K 0.01% 1742
2025
Q3 		$11.3M Buy
3,237,572
+2,386,367
+280% +$7.54M ﹤0.01% 2277
2025
Q2 		$2.21M Buy
851,205
+306,117
+56% +$631K ﹤0.01% 3795
2025
Q1 		$1.04M Buy
545,088
+511,231
+1,510% +$1.36M ﹤0.01% 4315
2024
Q4 		$49.1K Sell
33,857
-135,546
-80% -$225K ﹤0.01% 5597
2024
Q3 		$312K Sell
169,403
-264,352
-61% -$329K ﹤0.01% 5172
2024
Q2 		$434K Buy
433,755
+239,988
+124% +$351K ﹤0.01% 4676
2024
Q1 		$384K Sell
193,767
-300,325
-61% -$519K ﹤0.01% 4983
2023
Q4 		$771K Buy
494,092
+187,469
+61% +$324K ﹤0.01% 4347
2023
Q3 		$604K Buy
306,623
+143,157
+88% +$354K ﹤0.01% 4540
2023
Q2 		$520K Sell
163,466
-814,937
-83% -$2.56M ﹤0.01% 4510
2023
Q1 		$3.2M Buy
978,403
+896,456
+1,094% +$3.52M ﹤0.01% 2997
2022
Q4 		$412K Buy
81,947
+18,760
+30% +$74.8K ﹤0.01% 4877
2022
Q3 		$144K Buy
63,187
+35,326
+127% +$97.8K ﹤0.01% 5826
2022
Q2 		$74K Sell
27,861
-10,684
-28% -$23.2K ﹤0.01% 6040
2022
Q1 		$53K Buy
38,545
+27,388
+245% +$56.6K ﹤0.01% 6373
2021
Q4 		$35K Buy
+11,157
New +$37K ﹤0.01% 6540

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management's CMPX Position: Q2 2026 in Review

Millennium Management increased its Compass Therapeutics (CMPX) stake by 457% in Q2 2026, buying an estimated $11.4M and bringing the position to 4,713,247 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Millennium Management first reported a position in CMPX in Q4 2021 and has held it in 19 quarters since. The position peaked at $16.7M in Q4 2025. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Millennium Management held 4,713,247 shares of Compass Therapeutics worth $10.3M as of Q2 2026.
  • Millennium Management bought 3,867,027 Compass Therapeutics shares in Q2 2026, an estimated $11.4M.
  • Compass Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2248 holding.
  • Millennium Management first reported a position in Compass Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Millennium Management's Compass Therapeutics position peaked at $16.7M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.